● LIVE

OpenAI releases GPT-5 APIIndia AI startup raises $120MBitcoin ETF hits record inflowsMeta Llama 4 benchmarks leakedOpenAI releases GPT-5 APIIndia AI startup raises $120MBitcoin ETF hits record inflowsMeta Llama 4 benchmarks leaked

📅 Fri, 5 Jun, 2026✈️ Telegram

AI & Tech News

✈️ Follow

💻Technology

Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the risk of death for patients with advanced squamous non-small cell lung cancer. The data, filed with the Hong

⚡

Key Insights

10 editorial insights.

AiFeed24 Team·⏱ 1 min read·Technology

✈️ Telegram 𝕏 Tweet WhatsApp

Deep Analysis

Multi-Source Intelligence

Tags:#technology

Found this useful? Share it!

✈️ Telegram 𝕏 Tweet WhatsApp

Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Deep Analysis

Multi-Source Intelligence

Related Stories

Looks like Minecraft Dungeons II is coming in September

Alien Isolation 2's first trailer takes the horror to a colony planet

You Can Watch ‘The Odyssey’ Trailer in All Its Various Aspect Ratios Right Now

Pete Hegseth Struggles to Prevail in Battle with Anthropic

Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Deep Analysis

Multi-Source Intelligence

Related Stories

Looks like Minecraft Dungeons II is coming in September

Alien Isolation 2's first trailer takes the horror to a colony planet

You Can Watch ‘The Odyssey’ Trailer in All Its Various Aspect Ratios Right Now

Pete Hegseth Struggles to Prevail in Battle with Anthropic